Technical Insight on Equity Market – Research on Neothetics, Travelzoo, eGain and Minerva Neurosciences

NEW YORK, NY / ACCESSWIRE / December 1, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: Neothetics Inc (NASDAQ: NEOT), Travelzoo Inc (NASDAQ: TZOO), eGain Corp (NASDAQ: EGAN) and Minerva Neurosciences Inc (NASDAQ: NERV). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

NEOT Research Package: http://www.traders-choice.com/pdf?s=NEOT

TZOO Research Package: http://www.traders-choice.com/pdf?s=TZOO

EGAN Research Package: http://www.traders-choice.com/pdf?s=EGAN

NERV Research Package: http://www.traders-choice.com/pdf?s=NERV

============

Highlights from today’s reports include:

On Monday, November 30, 2015, NASDAQ ended at 5,108.67, down 0.37%, Dow Jones declined 0.44%, to finish the day at 17,719.92, and the S&P closed at 2,080.41, down 0.46%.

– Neothetics Inc’s stock edged lower by 1.30% to close Monday’s session at USD 9.13. The company’s shares oscillated between USD 8.98 and USD 9.57. The stock recorded a trading volume of 0.07 million shares, which was at par with its 50-day daily average volume of 0.07 million shares and below its 52-week average volume of 0.08 million shares. Over the last three days, Neothetics Inc’s shares have declined by 1.93% while in the past one week it has moved up 4.34%. Furthermore, over the last three months, the stock has lost 22.56% and in the past six months, the shares have picked up 44.69%. The stock has a market capitalization of USD 125.36 million and it is trading at Price to Book (mrq) ratio of 3.87. The last trading price of the stock was above its 50-Day Moving Average of USD 8.75 but below its 200-Day Moving Average of USD 9.79.

– The stock of Travelzoo Inc lost 1.51% to close Monday’s session at USD 8.50. The shares of the company moved in the range of USD 8.46 and USD 8.71. A trading volume of 0.03 million shares was recorded, which was lower than its 150-day daily average volume of 0.10 million shares and below its 52-week average volume of 0.13 million shares. Over the last five days, Travelzoo Inc’s shares have declined by 3.95% and in the past one month, it has lost 5.87%. Further, the company is trading at a price to earnings ratio of 9.34 and a price to book ratio of 5.68. This compares to a historical PE ratio of 11.43. The historical PB ratio is near to 5.19. Further, the stock is trading at a price to cash flow ratio of 7.59 and price to sales ratio of 0.94. The Company has a market capitalization of USD 125.21 million.

– eGain Corp’s stock increased by 3.60% to close Monday’s session at USD 4.60. The company’s shares fluctuated in the range of USD 4.38 and USD 4.70. A total of 0.02 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.01 million shares and was below its 52-week average volume of 0.05 million shares. Over the last three days eGain Corp’s shares have advanced 13.86% and in the past one week it has moved up 18.86%. Furthermore, over the last three months, the stock has gained 27.42% while in the past six months, the shares have shed 8.37%. The company has returned 26.37% in the past three months, and 1.10% in the last half year, on a compounded total return basis. The Company has a market capitalization of USD 124.34 million. The last trading price of the stock was above its 50-Day Moving Average of USD 4.37 and above its 200-Day Moving Average of USD 4.26.

– Minerva Neurosciences Inc’s stock slipped 0.20% to close Monday’s session at USD 5.02. The company’s shares oscillated between USD 4.99 and USD 5.08. The stock’s 52-week low was USD 4.20 and 52-week high was USD 10.00. The stock recorded a trading volume of 0.01 million shares, which was at par with its 50-day daily average volume of 0.01 million shares and below its 52-week average volume of 0.08 million shares. Over the last five days, Minerva Neurosciences Inc’s shares have declined by 1.76% and in the past one year, it has advanced 0.20%. The Company has a market capitalization of USD 124.10 million and it is trading at a Price to Book (mrq) ratio of 1.97. The last trading price of the stock was below its 50-Day Moving Average of USD 5.17 and below its 200-Day Moving Average of USD 5.49.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 434220